Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2022.1028576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Xiaoyu Duan und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Proctitis, Radiation Injuries. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Gansu Province.
Abstract (Originalsprache)
Objectives
This study aimed to investigate the protective effect of ginsenoside Rg3 (GRg3) against acute radiation proctitis (ARP) in rats.
Methods
Wistar rats were randomly divided into control, model, dexamethasone-positive, GRg3 low-dose, GRg3 medium-dose, and GRg3 high-dose groups. The ARP rat model was established by a single 22-Gy irradiation of 6 MV) X-rays. The distribution and function of intestinal flora were detected using 16S rRNA high-throughput sequencing, rectal tissue was observed by hematoxylin and eosin (H&E) staining, the expression of interleukin 1β (IL-1β) and IL-10 inflammatory factors was detected by ELISA, and mRNA and protein expression of toll-like receptor 4 (TLR4), myeloid differentiation primary response 88 (MyD88), and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) were detected by RT-qPCR and Western blotting, respectively.
Results
GRg3 improved the symptoms of ARP in rats in a dose-dependent manner. The species distribution of intestinal flora in GRg3 rats was significantly different from that in ARP rats. These differences were more significant in the high-dose group, where the numbers of Ruminococcus , Lactobacillus , and other beneficial bacteria were significantly increased, whereas those of Escherichia , Alloprevotella , and other harmful bacteria were decreased. In addition, GRg3 was closely related to amino acid metabolism. After GRg3 treatment, the mRNA and protein expression of TLR4, MyD88, and NF-κB in rectal tissue was significantly down-regulated, and the level of downstream inflammatory factor IL-1β decreased, whereas that of IL-10 increased.
Conclusion
Our study indicated GRg3 as a new compound for the treatment of ARP by inhibiting the TLR4/MyD88/NF-κB pathway, down-regulating the expression of proinflammatory factors, thus effectively regulating intestinal flora and reducing inflammatory reactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College of Gansu University of Chinese Medicine (Gansu Provincial Hospital), Lanzhou, China.
- Department of Radiotherapy, Gansu Provincial Hospital, Lanzhou, China.
Förderung
- Natural Science Foundation of Gansu Province
Zitieren
APA
Duan, X., Cai, H., Hu, T., Lin, L., Zeng, L., Wang, H., Cao, L., & Li, X. (2023). Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2022.1028576
Vancouver
Duan X, Cai H, Hu T, Lin L, Zeng L, Wang H, et al. Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2022.1028576
BibTeX
@article{Duan2023,
author = {Duan, Xiaoyu and Cai, Hongyi and Hu, Tingting and Lin, Lili and Zeng, Lu and Wang, Huixia and Cao, Lei and Li, Xuxia},
title = {Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2022.1028576}
}
EUVIMED